CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	May 31, 2012	May 31, 2011
Cash flows from operating activities
Net loss	$ (698,399)	$ (1,561,356)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	0	950
Stock-based compensation	120,716	650,928
Interest expense from amortization of discount on convertible debentures	5,000	10,000
Change in fair value of derivative liability	(43,964)	557,320
Changes in assets and liabilities
Grant receivable	303,102	(198,412)
Other current assets	987	(321)
Accounts payable and accrued liabilities	(29,952)	(219,232)
Deferred revenue	(24,659)	(24,658)
Net cash used in operating activities	(367,169)	(784,781)
Cash flows from investing activities	0	0
Cash flows from financing activities
Proceeds from the exercise of stock warrants	491,590	825,675
Advance from debenture holder	(193,895)	(25,675)
Net cash provided by financing activities	297,695	800,000
Net increase (decrease) in cash and cash equivalents	(69,474)	15,219
Cash and cash equivalents at beginning of period	405,327	634,377
Cash and cash equivalents at end of period	335,853	649,596
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	1,711	1,912
Noncash Investing and Financing Activities:
Issuance of common stock for conversion of 4.75% debentures	$ 4,510	$ 7,575